ISHARES TR - U.S. PHARMA ETF (IHE)

Historical Holders from Q1 2014 to Q1 2025

Symbol
IHE
CUSIP
464288836
Type / Class
Equity / U.S. PHARMA ETF
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
5.46M
Holdings value
$359M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
155
Number of buys
63
Number of sells
-49
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 107K $7.47M -$4.9M $70.56 24
2024 Q4 5.46M $359M +$8.07M $65.72 155
2024 Q3 5.29M $373M -$36.5M $70.61 143
2024 Q2 5.82M $386M +$20.4M $66.32 141
2024 Q1 5.57M $378M +$213M $67.90 138
2023 Q4 1.89M $351M +$241M $185.40 132
2023 Q3 650K $115M -$5.41M $176.98 124
2023 Q2 675K $121M -$9.71M $179.11 116
2023 Q1 730K $128M -$9.78M $175.28 124
2022 Q4 747K $139M +$8.76M $186.13 126
2022 Q3 692K $117M -$7.56M $169.54 108
2022 Q2 747K $143M +$34M $191.65 119
2022 Q1 562K $109M +$8.37M $194.24 116
2021 Q4 521K $104M -$3.38M $199.66 106
2021 Q3 535K $98.1M +$981K $183.13 107
2021 Q2 529K $98.2M +$6.46M $185.74 98
2021 Q1 494K $87.8M -$2.26M $177.66 99
2020 Q4 506K $90.9M +$3.77M $179.44 96
2020 Q3 486K $79.5M -$9.04M $163.53 91
2020 Q2 544K $83.7M +$14.1M $153.87 88
2020 Q1 451K $60.7M -$20.5M $134.58 91
2019 Q4 599K $95.8M -$71.2M $160.11 90
2019 Q3 1.05M $147M +$43.8M $139.85 81
2019 Q2 732K $110M +$8.53M $150.79 83
2019 Q1 675K $104M -$234K $153.97 89
2018 Q4 684K $96.3M -$28.9M $140.76 92
2018 Q3 878K $147M -$909K $167.84 95
2018 Q2 876K $133M -$9.9M $151.35 90
2018 Q1 944K $139M -$138M $147.54 99
2017 Q4 1.85M $285M -$31.4M $154.38 106
2017 Q3 2.03M $317M -$32.6M $156.36 99
2017 Q2 2.24M $347M -$14.5M $155.13 92
2017 Q1 2.3M $348M +$60.5M $150.94 95
2016 Q4 1.95M $276M +$115M $141.42 92
2016 Q3 1.08M $161M -$44.3M $149.44 84
2016 Q2 1.36M $197M -$20.5M $144.40 88
2016 Q1 1.49M $205M -$99.3M $136.98 90
2015 Q4 1.92M $309M -$760K $161.69 102
2015 Q3 2.16M $321M -$24.1M $148.02 102
2015 Q2 2.31M $404M -$49.6M $174.82 118
2015 Q1 2.54M $437M +$86.7M $172.42 107
2014 Q4 2.05M $311M +$27.1M $151.40 101
2014 Q3 1.84M $259M -$10.4M $140.35 85
2014 Q2 1.92M $259M -$2.84M $135.11 86
2014 Q1 1.95M $247M +$26.5M $126.69 85